2022
Hospital Frailty Risk Score and Healthcare Resource Utilization After Surgery for Primary Spinal Intradural/Cord Tumors
Elsamadicy AA, Koo AB, Reeves BC, Pennington Z, Sarkozy M, Hersh A, Havlik J, Sherman JJZ, Goodwin CR, Kolb L, Laurans M, Lo S, Shin JH, Sciubba DM. Hospital Frailty Risk Score and Healthcare Resource Utilization After Surgery for Primary Spinal Intradural/Cord Tumors. Global Spine Journal 2022, 13: 2074-2084. PMID: 35016582, PMCID: PMC10556884, DOI: 10.1177/21925682211069937.Peer-Reviewed Original ResearchHospital Frailty Risk ScoreNon-routine dischargeFrailty Risk ScoreImpact of frailtyCost of admissionDischarge dispositionFrail cohortPrimary tumorSpinal cordRisk scoreNationwide Inpatient Sample databaseRetrospective cohort studyHealthcare resource utilizationLength of stayPrimary spinal tumorsGreater mean costICD-10 codesICD-10-CM codesLarge national datasetPerioperative complicationsPostoperative complicationsAdult patientsCohort studyLonger LOSPatient characteristics
2020
Genetic characterization of a case of sellar metastasis from bronchial carcinoid neuroendocrine tumor
S ., Kundishora AJ, Elsamadicy AA, Koo AB, Beckta JM, McGuone D, Erson-Omay EZ, Omay SB. Genetic characterization of a case of sellar metastasis from bronchial carcinoid neuroendocrine tumor. Surgical Neurology International 2020, 11: 303. PMID: 33093980, PMCID: PMC7568119, DOI: 10.25259/sni_265_2020.Peer-Reviewed Original ResearchNeuroendocrine tumorsSellar metastasisVisual deficitsPrimary pituitary tumorsLung carcinoid tumorEndoscopic endonasal resectionActionable therapeutic targetsWhole-exome sequencingPituitary metastasisFinal pathologyPituitary involvementCarcinoid tumorsEndocrine dysfunctionHistopathological correlatesEndocrine abnormalitiesSystemic tumorsPrimary tumorSuprasellar lesionsMetastatic tumorsSellar tumorsEndonasal resectionPituitary tumorsGastrointestinal tractTherapeutic targetPituitary gland